CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $223.09M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 5.46: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
315.09BKRW223.09M · vs all stocks (USD)
Trailing P/E
7.61xRevenue (TTM)
96.04BKRW68.00M · vs all stocks (USD)
Profit Margin
25.89%Beta
0.1620xvs all stocks
52-Week Change
-33.07%vs all stocks
Market Capitalization
315.09BKRW223.09M · vs all stocks (USD)
Enterprise Value
320.09BKRW226.63M · vs all stocks (USD)
Trailing P/E
7.61xPEG Ratio
-0.0992xPrice to Sales (TTM)
3.61xPrice to Book (MRQ)
1.75xEnterprise to Revenue
3.33xEnterprise to EBITDA
4.46xGross Margin
54.60%Profit Margin
25.89%Operating Margin
35.19%Return on Assets (TTM)
17.18%Return on Equity (TTM)
23.53%Revenue (TTM)
96.04BKRW68.00M · vs all stocks (USD)
Revenue per Share (TTM)
4.07KKRWUpdated Aug 19, 2026Quarterly Revenue Growth
54.40%EBITDA (TTM)
60.30BKRW42.69M · vs all stocks (USD)
Net Income (TTM)
24.87BKRW17.61M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-60.41%Operating Cash Flow (TTM)
49.10BKRW34.77M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
41.26BKRW29.22M · vs all stocks (USD)
Payout Ratio
0.00%Revenue
149.20BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
63.00BKRWFY2025 · Dec 31, 2025Gross Profit
86.20BKRWFY2025 · Dec 31, 2025Operating Income
60.66BKRW42.95M · vs all stocks (USD)
Pre-tax Income
53.81BKRWFY2025 · Dec 31, 2025Income Tax Expense
12.54BKRWFY2025 · Dec 31, 2025Net Income
41.26BKRWFY2025 · Dec 31, 2025EBIT
54.80BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
71.71BKRWFY2025 · Dec 31, 2025Research & Development
13.21BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
4.61BKRWFY2025 · Dec 31, 2025Other Operating Expenses
336.30MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
1.57BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
994.40MKRWFY2025 · Dec 31, 2025EPS (Basic)
1.13KKRWFY2025 · Dec 31, 2025EPS (Diluted)
1.13KKRWFY2025 · Dec 31, 2025Basic Shares Outstanding
36.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
36.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
41.26BKRWFY2025 · Dec 31, 2025Operating Cash Flow
28.76BKRWFY2025 · Dec 31, 2025Free Cash Flow
23.23BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
23.67BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
41.26BKRWFY2025 · Dec 31, 2025Stock-based Compensation
657.82MKRWFY2025 · Dec 31, 2025Other Non-cash Items
-573.18MKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-7.60BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.99BKRWFY2025 · Dec 31, 2025Capital Expenditures
-5.53BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-5.18BKRWFY2025 · Dec 31, 2025Purchase of Investments
-50.67BKRWFY2025 · Dec 31, 2025Sale of Investments
15.50BKRWFY2025 · Dec 31, 2025Other Investing Activity
6.06BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-34.64BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-8.50BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-8.50BKRWFY2025 · Dec 31, 2025Other Financing Charges
243.40MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-15.83BKRWFY2025 · Dec 31, 2025Shares Outstanding
36.72MSharesUpdated Aug 19, 2026Float Shares
29.14MSharesUpdated Aug 19, 2026% Held by Insiders
23.30%vs all stocks
% Held by Institutions
8.36%vs all stocks
Total Cash (MRQ)
11.49BKRW8.14M · vs all stocks (USD)
Total Cash per Share (MRQ)
315.22KRWUpdated Aug 19, 2026Total Debt (MRQ)
14.78BKRW10.46M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1410xCurrent Ratio (MRQ)
3.99xBook Value per Share (MRQ)
4.90KKRWUpdated Aug 19, 2026Total Assets
240.23BKRW170.09M · vs all stocks (USD)
Total Current Assets
137.04BKRWFY2025 · Dec 31, 2025Total Liabilities
64.87BKRWFY2025 · Dec 31, 2025Total Non-current Assets
103.18BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
23.15BKRWFY2025 · Dec 31, 2025Total Current Liabilities
41.71BKRWFY2025 · Dec 31, 2025Cash Equivalents
23.67BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
23.67BKRWFY2025 · Dec 31, 2025Other Short-term Investments
51.04BKRWFY2025 · Dec 31, 2025Accounts Receivable
12.07BKRWFY2025 · Dec 31, 2025Inventory
38.30BKRWFY2025 · Dec 31, 2025Accounts Payable
5.50BKRWFY2025 · Dec 31, 2025Short-term Debt
974.49MKRWFY2025 · Dec 31, 2025Other Current Liabilities
-240.00KRWFY2025 · Dec 31, 2025Long-term Debt
3.02BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-340.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
18.34BKRWFY2025 · Dec 31, 2025Retained Earnings
119.28BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
175.36BKRW124.16M · vs all stocks (USD)
52-Week Low
6.95KKRWUpdated Aug 19, 202652-Week High
17.70KKRWUpdated Aug 19, 202652-Week Change
-33.07%vs all stocks
Beta
0.1620xvs all stocks
50-Day MA
8.61KKRWUpdated Aug 19, 2026200-Day MA
11.67KKRWUpdated Aug 19, 2026Avg 10-Day Volume
111.75KSharesUpdated Aug 19, 2026Avg 30-Day Volume
131.17KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
1.13KKRWUpdated Aug 19, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Revenue Growth With Elevated Margin
Revenue up in each of five years, while its operating margin stays high.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.46: safe zoneNotable
Altman Z-Score: 5.46
High structural barrier to entryNotable
Barrier to Entry: 0.77
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $223.09M, lower than 95% of all stocks globallySignificant
Market cap (USD): 223,093,473.073Global P5: 269,387,740.27
Levered free cash flow is $29.22M, above the global median of $16.24MNotable
Levered free cash flow (USD): 29,216,565.279Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Acimmune SA
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Anavex Life Sciences Corp.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Intocell Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Orchestra BioMed Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Samyang Biopharmaceuticals Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Invivyd Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Protara Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Coherus Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Terrascend Corp.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Koa Shoji Holdings Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Aurinia Pharmaceuticals Inc.
3 interpretationsRevenue Growth With Elevated MarginOperating Income Growing With Multi-Year Revenue GrowthMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Wuhan Dameng Database Co., Ltd.
3 interpretationsRevenue Growth With Elevated MarginOperating Income Growing With Multi-Year Revenue GrowthMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Data Patterns (India) Limited
3 interpretationsRevenue Growth With Elevated MarginOperating Income Growing With Multi-Year Revenue GrowthMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities